Market Research Reports

According to IMARC Group’s latest report, titled “ Sepsis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the global sepsis diagnostics market is expected to exhibit a CAGR of 9.2% during 2022-2027 . Sepsis diagnostics include immunoassays, molecular diagnosis, microfluidics, biomarkers, and flow cytometry. These diagnostic procedures assist in guiding initial treatment, monitoring the progression of infection, evaluating patient response to the treatment, and reducing symptoms caused due to sepsis. Presently, they are extensively utilized in hospitals, pathology and reference laboratories, and academic research institutes across the globe. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Request for a PDF sample of this report: https://www.imarcgroup.com/sepsis-diagnostics-market/requestsample ...

According to IMARC Group’s latest report, titled “ Sepsis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ”, the   global  sepsis diagnostics market  grew at a CAGR of around 8% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit continuous growth during 2021-2026.  Sepsis diagnostics include immunoassays, molecular diagnosis, microfluidics, biomarkers, and flow cytometry. These diagnostic procedures assist in guiding initial treatment, monitoring the progression of infection, evaluating patient response to the treatment, and reducing symptoms caused due to sepsis. Presently, they are extensively utilized in hospitals, pathology and reference laboratories, and academic research institutes across the globe. As the novel coronavirus  (COVID-19)  crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumer...